Ontera was founded with the mission to revolutionize molecular diagnostics by leveraging advanced technology to provide precise and rapid DNA/RNA examination. The company's core vision is to enable accurate detection and differentiation of single molecules using their innovative silicon nanopore chips and proprietary biochemistry. Ontera's platform is designed for applications across various fields, including medical health, agriculture, and environmental science, aiming to deliver impactful solutions for complex biological challenges.

Notable figures associated with Ontera include key scientists and technologists who have contributed significantly to the development of their cutting-edge platform. The company has attracted investment from prominent venture capital firms, underscoring its potential in the biotech industry. Ontera's achievements include the successful deployment of their technology in real-world scenarios, demonstrating its efficacy and reliability. Their work has had a substantial impact on improving diagnostic capabilities, offering faster and more accurate results that benefit multiple sectors.